FIA
OMIC

FNY Investment Advisers’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

FNY Investment Advisers’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-783
Closed -$89K – 892
2022
Q2 		$89K Buy
783
+400
+104% +$46.9K 0.07% 169
2022
Q1 		$72K Buy
383
+216
+129% +$50K 0.07% 203
2021
Q4 		$57K Buy
+167
New +$64.7K 0.03% 245

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

FNY Investment Advisers's OMIC Position: Q3 2022 in Review

FNY Investment Advisers sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q3 2022, closing a stake of 783 shares — an estimated $89K sold.

FNY Investment Advisers first reported a position in OMIC in Q4 2021 and held it in 3 quarters. The position peaked at $89K in Q2 2022. 74 funds tracked by Wall St. Rank hold OMIC as of Q3 2022.

  • FNY Investment Advisers reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 783 Singular Genomics Systems, Inc. Common Stock shares in Q3 2022, an estimated $89K.
  • FNY Investment Advisers first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • FNY Investment Advisers's Singular Genomics Systems, Inc. Common Stock position peaked at $89K in Q2 2022.
  • 74 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.